- Member Since: July 25, 2025
The companies that are able to consistently find good licensing opportunities are the ones that assess programmes throughout the clinical drug development process and consider […]
30 total views, 3 today
The pharmaceutical industry is spending over $300 billion annually on R&D. Timelines are lengthening. Margins are narrowing. And 80 to 85% of clinical trials are […]
27 total views, 1 today
Pharmaceutical companies are moving into a new era where they have to rely on scientific innovations as well as the capacity to interpret the data […]
37 total views, 1 today
The era of traditional pipeline reporting and prospects for AI-driven data-driven clinical drug development are transforming into an era of real-time, predictive intelligence. More Info: […]
38 total views, 0 today